Document is current
Any future updates will be listed below
-
Authors
Bach-Morrow, Lana
Boccalatte, Francesco
DeRosa, Antonio
Devos, David
Garcia-Sanchez, Carmen
Inglese, Matilde
Droby, Amgad
- License Information
-
More Information
Article History
Received: 25 July 2021
Accepted: 9 November 2022
First Online: 24 November 2022
Competing interests
: David Devos has received the European Union’s Horizon 2020 research and innovation program under grant agreement No 633190, the H2020 Eurostar grant, the European ANR the project COEN4007 - 18-COEN-0003-01, PHRC grants from the French Ministry of Health and research funding from France Parkinson and ARSLA charity. He has served on the Scientific Advisory Board for Abbvie, Apopharma, Alterity, Abfero, Alzprotect, Orkyn, and Boston Scientific and received various honoraria from pharmaceutical companies for consultancy and lectures on Parkinson’s disease at symposia. Lana Bach-Morrow is C.E.O. and founder of Think Interfaces, Inc. The remaining authors have no conflicts of interest to declare.
